Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibition of imatinib transport by uremic toxins during renal failure.

× No keyword cloud information.

6 in total

Review 1. Practical guidelines for dose individualization of anticancer targeted drugs.

Authors: María Isabel Sáez; Cristina Quero; José Manuel Trigo; Begoña Muros; Emilio Alba
Journal: Clin Transl Oncol Date: 2012-10-12 Impact factor: 3.405

2. Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer.

Authors: Roisin M Connolly; Michelle A Rudek; Elizabeth Garrett-Mayer; Stacie C Jeter; Michele G Donehower; Laurie A Wright; Ming Zhao; John H Fetting; Leisha A Emens; Vered Stearns; Nancy E Davidson; Sharyn D Baker; Antonio C Wolff
Journal: Breast Cancer Res Treat Date: 2011-02-25 Impact factor: 4.872

3. Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on pyrimidines, pyridines and pyrroles.

Authors: Paola Di Gion; Friederike Kanefendt; Andreas Lindauer; Matthias Scheffler; Oxana Doroshyenko; Uwe Fuhr; Jürgen Wolf; Ulrich Jaehde
Journal: Clin Pharmacokinet Date: 2011-09 Impact factor: 6.447

Review 4. Pharmacogenetics of the organic anion transporting polypeptide 1A2.

Authors: Ryan M Franke; Lisa A Scherkenbach; Alex Sparreboom
Journal: Pharmacogenomics Date: 2009-03 Impact factor: 2.533

Review 5. Individualized Management of Blood Concentration in Patients with Gastrointestinal Stromal Tumors.

Authors: Hao Xu; Qi Liu
Journal: Onco Targets Ther Date: 2021-01-05 Impact factor: 4.147

Review 6. Imatinib, sunitinib and pazopanib: From flat-fixed dosing towards a pharmacokinetically guided personalized dose.

Authors: Kim Westerdijk; Ingrid M E Desar; Neeltje Steeghs; Winette T A van der Graaf; Nielka P van Erp
Journal: Br J Clin Pharmacol Date: 2020-01-21 Impact factor: 4.335

6 in total